The Quest for a Fountain of Youth
Discovering the fountain of youth has long been a human pursuit. Recently, a technique called therapeutic plasma exchange has garnered attention for its potential to reverse the aging process. In a 2025 study published in Aging Cell, researchers explored the effects of this procedure on biological age.
Therapeutic plasma exchange involves filtering and replacing the liquid portion of a person’s blood. This process is not a new concept; it has been used to treat certain autoimmune diseases, neurological disorders, and blood cancers. However, its potential as an anti-aging elixir has sparked interest in the scientific community.
According to Dr. Andrea Maier, a geriatrician and board member of the Academy for Health and Lifespan Research, plasma is more than just the liquid surrounding red and white blood cells in the bloodstream. It is a transport system rich in proteins, metabolites, hormones, and inflammatory signals. These molecules reflect and influence what is happening across an individual’s organ systems, making plasma a smart focal point for longevity studies.
By measuring changes in the levels of thousands of circulating proteins in plasma, researchers can gain insight into a person’s biological age. This concept is not a fixed or precise measurement but rather a helpful health indicator. Dr. Keenan Walker, a senior investigator at the National Institute on Aging, explains that people’s biological ages can be older or younger than their chronological age, and this discrepancy can increase the risk of chronic conditions, diseases, and mortality.
The connection between plasma and the aging process was first explored about 15 years ago using a process called parabiosis. This technique involves surgically linking the circulatory systems of two different organisms, such as old mice and young mice. Researchers found that circulating younger plasma in an older organism could have beneficial effects, leading to the development of plasma exchange as a treatment for certain conditions.
The 2025 study enrolled 42 participants and exchanged their plasma with purified albumin and saline. Some participants also received a type of immune therapy called IVIG. The researchers measured changes in the participants’ bodies using advanced lab tests that track aging at the molecular level. The results showed that some participants reduced their biological age by approximately 2.5 years, but this effect was nearly gone by the end of the study.
Dr. Maier points out that the data from the study came from the middle of the study, not the end. This means that the participants’ bodies may have experienced stress as they adapted to the major change in their plasma, causing their biomarkers to swing back to their original levels. In other words, the rejuvenation seen in the short-term may be temporary.
The study also found that participants with poorer health saw a stronger intervention effect. This suggests that the effectiveness of plasma exchange as an anti-aging treatment may depend on the individual’s overall health. Dr. Walker notes that this is an important consideration for future studies.
Both Drs. Maier and Walker see promise in blood-based interventions for improving overall health but emphasize the need for a more personalized approach rather than a generalized non-specific plasma filtering process.
Dr. Maier describes the study as a phase 1 study, where the focus is on safety and feasibility. She emphasizes that the results are promising but need to be replicated in larger studies with longer-term effects. The future of this research is exciting, but it is essential to approach it with caution and precision.
